Approval · Notice of Compliance 34566 · 2024
SATIVEX: Notice of Compliance 34566
Issued December 17, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34566
- Date
- December 17, 2024
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in manufacturer name
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SATIVEX | 02266121 | Marketed |
Medicinal ingredients
- DELTA-9-TETRAHYDROCANNABINOL 27 MG per ML
- CANNABIDIOL 25 MG per ML